Sponsors
The bill strengthens sickle cell surveillance and restores CDC capacity and workers—improving data for patients and public health—but does so at modest additional federal cost and with potential administrative burdens and privacy risks.
People with sickle cell disease and researchers will get better, standardized surveillance data on incidence, prevalence, and care patterns, enabling more targeted services, research, and treatment design.
Restoring staff at the CDC Division of Blood Disorders and Public Health Genomics will improve federal capacity for blood-disorder surveillance and genomic public‑health work, supporting nationwide monitoring and response.
State health departments will receive federal grants to build surveillance capacity and standardize methods across jurisdictions, improving data consistency and state-level public health capabilities.
Taxpayers face increased federal costs (surveillance program funding plus payroll/administrative costs to reinstate staff) totaling additional spending over the five-year period, which could add to deficits or crowd out other priorities.
If data privacy protections are insufficient, individuals with sickle cell disease could face risks to personal privacy or misuse of sensitive health data.
State and local health agencies may face added administrative burden to build and maintain surveillance systems and comply with standardization and reporting requirements.
Based on analysis of 3 sections of legislative text.
Establishes a CDC sickle cell data grant program with $10M/year (FY2027–2031) and requires reinstatement of certain CDC Division of Blood Disorders employees removed after Jan 1, 2025.
Introduced March 24, 2026 by Eugene Simon Vindman · Last progress March 24, 2026
Creates a CDC-run Sickle Cell Data Collection grant program to fund states that collect standardized data on sickle cell disease (incidence, prevalence, demographics, and health care use) and authorizes $10 million per year for fiscal years 2027–2031. It also requires the Department of Health and Human Services to reinstate certain employees of the CDC Division of Blood Disorders and Public Health Genomics who were removed on or after January 1, 2025 as part of a workforce reduction or reorganization that eliminated at least 3% of that Division’s staff within a 60-day period. One provision in the bill provides the Act’s short title and has no substantive legal effect.